Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

Clicks: 17
ID: 289972
1991
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #336 of 413 articles by views in JNCI Journal of the National Cancer Institute

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 413 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Journal Article Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines Get access Anne Monks, Anne Monks * Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. * Correspondence to: Anne Monks, PhD, NCl-Frederick Cancer Research and Development Center, Bldg 432, Rm 232, Frederick, MD 21701-1013 Search for other works by this author on: Oxford Academic PubMed Google Scholar Dominic Scudiero, Dominic Scudiero Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Philip Skehan, Philip Skehan Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Robert Shoemaker, Robert Shoemaker Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Kenneth Paull, Kenneth Paull Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar David Vistica, David Vistica Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Curtis Hose, Curtis Hose Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar John Langley, John Langley Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Paul Cronise, Paul Cronise Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Anne Vaigro-Wolff, Anne Vaigro-Wolff Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar ... Show more Marcia Gray-Goodrich, Marcia Gray-Goodrich Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Hugh Campbell, Hugh Campbell Program Resources, Inc., NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Joseph Mayo, Joseph Mayo Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar Michael Boyd Michael Boyd Developmental Therapeutics Program, Division of Cancer Treatment, NCI-Frederick Cancer Research and Development CenterFrederick, Md. Search for other works by this author on: Oxford Academic PubMed Google Scholar JNCI: Journal of the National Cancer Institute, Volume 83, Issue 11, 5 June 1991, Pages 757–766, https://doi.org/10.1093/jnci/83.11.757 Published: 05 June 1991 Article history Received: 19 November 1990 Revision received: 08 March 1991 Accepted: 20 March 1991 Published: 05 June 1991
Reference Key
openalex_W2155208683 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Anne Monks, Dominic A. Scudiero, Philip Skehan, Robert H. Shoemaker, Kenneth D. Paull, David T. Vistica, Curtis Hose, James W. Langley, P. Cronise, Anne Vaigro-Wolff, M. Gray-Goodrich, H. Campbell, J. Mayo, Marie Boyd
Are you one of these authors? Claim your profile
Journal JNCI Journal of the National Cancer Institute
Year 1991
DOI
10.1093/jnci/83.11.757
URL
https://doi.org/10.1093/jnci/83.11.757
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.